- Look Ahead: 'Risk On' Attitude Could Fuel Rally Further
- European Commission Objects to Sun Micro-Oracle Deal
- Obama Sees Strains Unless US, China Balance Growth
- JPMorgan Lifts Salary Freeze Amid Recovery
- Can Apple Top Microsoft as Most Valuable Tech Firm?
- Buffett to Sell Stakes in Norfolk Southern, Union Pacific
- Do You Know Your Coca-Cola Myths?
- Cramer: 5 Stocks to Play the Next Bull Run
- Electronic Arts Beats Street, Announces 1,500 Job Cuts
- Why Google is Paying $750 Million for Ad Mob
- Warren Buffett to Sell Stakes In Union Pacific & Norfolk Southern
- Nov. 9: Unusual Volume Leaders
- The Battered Businesses Behind Housing
- Modern Warfare 2's Record-Breaking Launch
- Merck’s Mega-Monday Morning
- Why are Traders Bullish on This Food Company?
- Profiting From Natural Gas: Strategists
- S&P Stocks Trading at New 52-Week Highs
- Madoff's personal effects go on the block
- Mexico's inflation rate 4.5 percent in October
- Judge: Evidence allowed in ex-KB home chief trial
- Judge: Evidence allowed in ex-KB Home exec's trial
- Another Disney studio executive exits
- Hawker Beechcraft to close Salina, Kan., plant
- Media mogul Rupert Murdoch threatens to sue BBC
- Ralcorp Holdings says Post Foods president resigns
- Duke Realty COO Robert Chapman resigns
LOUISVILLE, Ky. - Health insurer Humana Inc., whose robust government business has helped produced healthy profits, reports third-quarter results on Monday. Here are key developments related to that period.
OVERVIEW: Much of the attention from health insurers, and their investors, has focused on Washington, D.C., and the efforts to overhaul the country's health care system. Health insurers have watched nervously as Congress considers a provision for a government-sponsored insurance plan that would compete with them.
Humana's profits have been fueled by its strong government business, led by Medicare Advantage offerings, while its commercial segment has endured sluggishness linked to a badly weakened economy.
The company based in Louisville, Ky., has about 1.4 million Medicare Advantage enrollees, and the program accounts for about half the company's revenue. Medicare Advantage plans are government-sponsored, privately run programs for seniors that offer comprehensive health coverage.
Membership in Humana's stand-alone Medicare prescription drug plans has fallen in the past year, due mainly to low-income seniors joining other plans as well as some members switching to Medicare Advantage plans.
Reflecting the sour economy, pretax earnings in Humana's commercial segment fell 53 percent in the second quarter, due mainly to lower investment income and lower income from its small group business.
Still, Humana posted a robust profit in the second quarter, based on its strong government business. The company reported net income of $281.8 million, or $1.67 per share, for the quarter, compared with earnings of $209.9 million, or $1.24 per share, a year ago. Revenue jumped 8 percent to just under $7.9 billion.
BY THE NUMBERS: Analysts surveyed by Thomson Reuters expect, on average, earnings of $1.77 per share on $7.82 billion in revenue in the third quarter.
Humana earned $1.49 per share in the third quarter a year ago, which excluded a loss of 40 cents per share related to a downturn in its investment and securities lending porfolios and the sale of distressed financial institution securities. Humana posted quarterly revenue of $7.15 billion.
ANALYST TAKE: Oppenheimer analyst Carl McDonald said in a research note that he expects Humana to report earnings of $1.80 per share, 3 cents better than the Wall Street consensus.
McDonald predicted that the sector's Medicare-focused plans "are poised to have a very strong quarter." He said that the sector's commercial plans are facing "cost pressure," and that "a big drop in membership this year will make it difficult for most plans to show any commercial earnings growth in 2010."
He said anticipation for the industry's earnings season isn't as great as normal — "mainly because everyone seems to realize that earnings will matter for about a day, and then the focus will immediately turn back to the machinations of Congress as soon as all the major plans have reported."
WHAT'S AHEAD: A strong performance by Humana's government business will be crucial to offset expected softness in its commercial sector amid the weak economy.
STOCK PERFORMANCE: Humana shares rose $4.78, or 15 percent, to $37.30 in the third quarter. The Standard & Poor's 500 index rose 14 percent during the same time.
- Do free market libertarians really believe what they say about ethics and shareholder value? The Big Money takes a look.
- Cramer did the research and found eight stocks that lead the pack. Read on to get his top picks.
- On the anniversary of the fall of the Berlin Wall, many in the former Eastern Bloc recall communism fondly.
- Software, biotech firms, even banks are watching a particular Supreme Court argument today.
- From politicians to CEOs to companies, here's your chance to vote for the winners and losers of 2009.
- A new sinister Internet viruses can turn you into an unsuspecting collector of child pornography.








